Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: Canada Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20063
20075
20084
20092
20102
20114
20124
20131
20152
20161
20172
20181
20191
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated11
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S5
AstraZeneca3
Novartis Pharmaceuticals3
Eli Lilly and Company2
GlaxoSmithKline2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
University Health Network, Toronto2
University of Manitoba2
Akcea Therapeutics1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus40
Diabetes Mellitus, Type 214
Diabetes Mellitus, Type 17
Obesity4
Hypertension3
Insulin Resistance3
Kidney Diseases3
Diabetic Nephropathies2
Hyperlipidemias2
Hypertriglyceridemia2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.